Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on May 22, 2025
Drilling Intersects 152.5 Metres Grading 0.46% Copper and 0.97 g/t Gold at Mount Polley
GlobeNewswire
·
May 22, 2025
VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) reports initial diamond drill results from the Mount Polley 2025 exploration program with a notable interval of 152.5 metres …
إطلاق منصة جديدة مدعومة بالذكاء الاصطناعي لتعزيز توظيف الشباب الإماراتي
EIN Presswire
·
May 22, 2025
إطلاق «مسار الغرير» لتعزيز فرص توظيف الشباب الإماراتي عبر الذكاء الاصطناعي، من خلال مسارات مخصّصة وتوصيات تدريبية وربط مباشر مع سوق العمل DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /EINPresswire.com/ -- 22 مايو 2025 – دبي، الإمارات العربية المتحدة: أطلقت …
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20% Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advanced Melanoma Previously Treated with Immune Checkpoint Inhibitor SAN CARLOS, …
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
GlobeNewswire
·
May 22, 2025
- 63% response rate observed among 43 evaluable patients - 79% overall survival rate at 12-months; 9 months median progression-free survival - Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 22, …
Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
– Results from KOMET-001 registration-directed trial of ziftomenib in R/R NPM1-m AML patients selected for oral presentation on Monday, June 2nd – – Encore presentation planned at EHA 2025 Congress – – Kura Oncology to host virtual investor event at 7:30pm …
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
GlobeNewswire
·
May 22, 2025
An oral presentation at ASCO …
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
GlobeNewswire
·
May 22, 2025
· BI 765063 in combination with programmed cell death-1 (PD1) inhibitor antibody ezabenlimab + cetuximab demonstrated a well-tolerated safety profile and potentially promising efficacy signals as second-line treatment in patients with recurrent/ …
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
May 22, 2025
CTLA-4 inhibitor ADG126 can be dosed at 20 mg/kg Q6W in combination with pembrolizumab with <20% Grade 3 adverse events In combination with pembrolizumab, ADG126 showed a 29% confirmed overall response rate (ORR) in microsatellite stable colorectal cancer …
Acceleware Ltd. Reports First Quarter 2025 Financial and Operating Results
GlobeNewswire
·
May 22, 2025
CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), an advanced electromagnetic (“EM”) heating company with highly scalable solutions for large industrial applications, today announced its …
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
GlobeNewswire
·
May 22, 2025
Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodies Long-term outcomes and survival data for Ziihera® (zanidatamab-hrii), which was developed using Azymetric™, to be presented at …
COOFANDY Marks 10th Anniversary with Dual Silver Awards at Berlin and New York Product Design Competitions
GlobeNewswire
·
May 22, 2025
New York, NY, May 22, 2025 (GLOBE NEWSWIRE) -- As COOFANDY celebrates its 10th anniversary in 2025, the brand has reached an exciting new milestone: The COOFANDY Men’s Short-Sleeve Casual Shirts have earned Silver Awards at both the 2025 Berlin Design …
A new passive income solution for 2025: Efficiently participate in Bitcoin and cryptocurrency mining with PairMiner
GlobeNewswire
·
May 22, 2025
Washington, D.C., USA, May 22, 2025 (GLOBE NEWSWIRE) -- PAIRMiner, an advanced platform offering mining power services. Recently, Bitcoin has made a strong comeback, with its price soaring and reigniting global investors' passion and confidence in …
Best Dogecoin & Bitcoin Mining Site of 2025: FioBit Launches the Most Profitable AI Cloud Miner to Help Crypto Investors Earn Faster
GlobeNewswire
·
May 22, 2025
Sydney, Australia, May 22, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market continues to mature in 2025, cloud mining has emerged as a cornerstone for both beginners and experienced investors seeking passive income through Bitcoin(BTC) and Dogecoin( …
Clear Blue Technologies International to provide Corporate Update and Report Q1 2025 Financial Results and Host Conference Call on Thursday, May 29th, 2025
GlobeNewswire
·
May 22, 2025
TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (TSXV: CBLU) the Smart Off-Grid™ Company, today announces that it will provide a corporate update and also report financial results for its first quarter 2025 on Wednesday …
Bank of Baroda UAE Partners with In-Solutions Global to Launch Jaywan Cards in UAE
EIN Presswire
·
May 22, 2025
DUBAI, UNITED ARAB EMIRATES, May 22, 2025 /EINPresswire.com/ -- JP Morgan-backed fintech venture, In-Solutions Global (ISG), has partnered with Bank of Baroda UAE to launch Jaywan Cards in the UAE. This collaboration reinforces ISG’s commitment to …
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
GlobeNewswire
·
May 22, 2025
- Renowned neuroscience drug developer joins to support strategic development of long-acting CNS therapeutics – HUNTSVILLE, AL, May 22, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology …
aqua’s AI Copilot – New AI-Powered Feature for Simplifying Test Management
EIN Presswire
·
May 22, 2025
NY, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- QA teams worldwide are increasingly moving toward automation through cloud test management solutions. Aqua Cloud has launched its new AI Copilot, a test management suite designed to streamline testing …
Divorce-Online Reports Rise in Clients Citing Emotional Attachment to AI Companions as Factor in Divorce
EIN Presswire
·
May 22, 2025
AI Infidelity? Why Some UK Couples Are Splitting Over Virtual Relationships SWINDON, WILTSHIRE, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- UK-based online divorce provider Divorce-Online has reported a notable increase in clients referencing …
AeroDelft First Student Team to Test Liquid Hydrogen Aircraft Propulsion System
EIN Presswire
·
May 22, 2025
DELFT, NETHERLANDS, May 22, 2025 /EINPresswire.com/ -- AeroDelft, a fully student-run and student-owned non-profit foundation based in Delft, has become the first student team in the world to design, build, and test an electric aircraft propulsion …
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
GlobeNewswire
·
May 22, 2025
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, …